Nanomedicine for the prevention, treatment and imaging of atherosclerosis.

Nanomedicine for the prevention, treatment and imaging of atherosclerosis.

Show other versions (2)

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in developed countries, with an increasing prevalence due to an aging population. The pathology underpinning CVD is atherosclerosis, a chronic inflammatory state involving the arterial wall. Accumulation of low density lipo...

書目詳細資料
Main Authors:	Psarros, C, Lee, R, Margaritis, M, Antoniades, C
格式:	Journal article
語言:	English
出版:	2012

相似書籍

Nanomedicine for the prevention, treatment and imaging of atherosclerosis
由: Psarros, C, et al.
出版: (2012)

Nanomedicine for the prevention, treatment and imaging of atherosclerosis.
由: Psarros, C, et al.
出版: (2012)

Nanomedicine for Diagnosis and Treatment of Atherosclerosis
由: Jingyun Cheng, et al.
出版: (2023-12-01)

Construction of dual nanomedicines for the imaging and alleviation of atherosclerosis
由: Shuihua Zhang, et al.
出版: (2020-01-01)

Nanomedicine-based drug delivery strategies for the treatment of atherosclerosis
由: Yongfang Lin, et al.
出版: (2024-06-01)

The role of adiponectin at different stages of atherosclerosis in heart failure: associations with myocardial redox state
由: Antonopoulos, A, et al.
出版: (2010)

Nanoparticles: a promising therapeutic approach in atherosclerosis.
由: Antoniades, C, et al.
出版: (2010)

Biomimetic nanomedicines for precise atherosclerosis theranostics
由: Ying Tao, et al.
出版: (2023-11-01)

Editorial: Advances on targeted nanomedicines for atherosclerosis
由: Qinggong Han, et al.
出版: (2022-10-01)

Macrophage-targeted nanomedicine for the diagnosis and management of atherosclerosis
由: Ping Ping Hu, et al.
出版: (2022-09-01)

Novel therapeutic strategies targeting vascular redox in human atherosclerosis.
由: Antonopoulos, A, et al.
出版: (2009)

Advanced targeted nanomedicines for vulnerable atherosclerosis plaque imaging and their potential clinical implications
由: Xue Li, et al.
出版: (2022-10-01)

Statin treatment improves vascular redox state through a tetrahydrobiopterin-mediated re-coupling of endothelial nitric oxide synthase, in human atherosclerosis
由: Antoniades, C, et al.
出版: (2011)

Precision nanomedicine in atherosclerosis therapy: how far are we from reality?
由: Yee Shan Wong, et al.
出版: (2019-01-01)

Multifunctional phototheranostic nanomedicine for cancer imaging and treatment
由: D. Gao, et al.
出版: (2020-01-01)

Interrelationships between vascular superoxide and adiponectin biosynthesis in perivascular adipose tissue in human atherosclerosis
由: Bakogiannis, C, et al.
出版: (2010)

Shedding new light on atherosclerosis therapeutics: Nanomedicines targeting atherosclerotic immune microenvironment
由: Zhiyue Wang, et al.
出版: (2024-12-01)

Nanomedicine for renal cell carcinoma: imaging, treatment and beyond
由: Ruolin Wu, et al.
出版: (2023-01-01)

Adiponectin as a regulator of vascular redox state in human atherosclerosis
由: Margaritis, M
出版: (2016)

Macrophage-targeting Antisenescence nanomedicine enables in-Situ NO induction for Gaseous and antioxidative atherosclerosis intervention
由: Yuanyuan Peng, et al.
出版: (2025-06-01)

L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis?
由: Siasos, G, et al.
出版: (2007)

A novel cross-talk between perivascular adipose tissue and the arterial wall controls redox state in human atherosclerosis
由: Margaritis, M, et al.
出版: (2013)

A NOVEL CROSS-TALK BETWEEN PERIVASCULAR ADIPOSE TISSUE AND THE ARTERIAL WALL CONTROLS REDOX STATE IN HUMAN ATHEROSCLEROSIS
由: Margaritis, M, et al.
出版: (2013)

Macrophage membrane-functionalized manganese dioxide nanomedicine for synergistic treatment of atherosclerosis by mitigating inflammatory storms and promoting cholesterol efflux
由: Sijin Chen, et al.
出版: (2024-10-01)

Insulin-induced vascular redox dysregulation in human atherosclerosis is ameliorated by dipeptidyl peptidase 4 inhibition
由: Akoumianakis, I, et al.
出版: (2020)

Insulin Treatment Induces Oxidative Stress in the Vascular Wall of Patients With Atherosclerosis Independently of Diabetes or Systemic Insulin Resistance: The Protective Role of DPP-IV Inhibition
由: Akoumianakis, I, et al.
出版: (2018)

An immunoregulator nanomedicine approach for the treatment of tuberculosis
由: Luona Yang, et al.
出版: (2023-05-01)

Challenges to Safe Nanomedicine Treatment
由: Chunhua Yang, et al.
出版: (2023-03-01)

Biomarkers of premature atherosclerosis.
由: Kampoli, A, et al.
出版: (2009)

Nanomedicine: Engineering of a tri-imageable nanoparticle for diagnostics
由: Bumb, A, et al.
出版: (2009)

Prevention and Regression of Atherosclerosis: Emerging Treatments
由: Aliosvi Rodríguez Rodríguez, et al.
出版: (2014-06-01)

Statins in coronary artery bypass grafting surgery: lipid lowering and beyond.
由: Margaritis, M, et al.
出版: (2012)

The role of perivascular fat in the diagnosis and prognosis of atherosclerosis
由: Polkinghorne, M, et al.
出版: (2022)

Homocysteine lowering: any use in atherosclerosis?
由: Antoniades, C, et al.
出版: (2007)

Atorvastatin rapidly reduces myocardial superoxide and peroxynitrite generation in human atherosclerosis, by suppressing NADPH-oxidase activity independently of LDL lowering
由: Antoniades, C, et al.
出版: (2011)

Nanomedicine Explored at Molecular Imaging Summit
由: Julie L. Sutcliffe PhD
出版: (2011-01-01)

The Role of Optical Imaging in Translational Nanomedicine
由: Evelien Hesemans, et al.
出版: (2022-08-01)

Advances in nanomedicines for lymphatic imaging and therapy
由: Pan He, et al.
出版: (2023-08-01)

Nanomedicine for Imaging and Therapy of Pancreatic Adenocarcinoma
由: Giulia Brachi, et al.
出版: (2019-11-01)

Perivascular adipose tissue and coronary atherosclerosis
由: Mancio, J, et al.
出版: (2018)